These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1719338)

  • 41. The role of growth hormone in diabetes mellitus.
    Holly JM; Amiel SA; Sandhu RR; Rees LH; Wass JA
    J Endocrinol; 1988 Sep; 118(3):353-64. PubMed ID: 3053958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment.
    Gil-Peña H; Garcia-Lopez E; Alvarez-Garcia O; Loredo V; Carbajo-Perez E; Ordoñez FA; Rodriguez-Suarez J; Santos F
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F639-45. PubMed ID: 19587145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
    Donahue LR; Beamer WG
    J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
    Smyczynska J; Hilczer M; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes.
    Batch JA; Werther GA
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):411-6. PubMed ID: 1424174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
    Tönshoff B; Schaefer F; Mehls O
    Pediatr Nephrol; 1990 Nov; 4(6):654-62. PubMed ID: 2088470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM; Julius JR; Stoppani C; Rundle AC
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
    Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two cases of insulin-dependent diabetes mellitus under insulin treatment with slow height velocity: relationship of growth hormone-binding protein, metabolic control and growth.
    Murata A; Yasuda T; Niimi H
    Acta Paediatr Jpn; 1994 Jun; 36(3):272-5. PubMed ID: 8091976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation.
    Zadik Z; Landau H; Chen M; Altman Y; Lieberman E
    J Clin Endocrinol Metab; 1992 Aug; 75(2):412-6. PubMed ID: 1386373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone insensitivity associated with elevated circulating growth hormone-binding protein in children with Alagille syndrome and short stature.
    Bucuvalas JC; Horn JA; Carlsson L; Balistreri WF; Chernausek SD
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1477-82. PubMed ID: 8501153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary protein restriction decreases insulin-like growth factor I independent of insulin and liver growth hormone binding.
    Maiter D; Fliesen T; Underwood LE; Maes M; Gerard G; Davenport ML; Ketelslegers JM
    Endocrinology; 1989 May; 124(5):2604-11. PubMed ID: 2523305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance.
    Quin JD; Checkley A; Gallagher A; Jones J; MacCuish AC; Miell JP
    J Endocrinol; 1994 Apr; 141(1):177-82. PubMed ID: 7516962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone axis in chronic kidney disease.
    Mahesh S; Kaskel F
    Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.